UK: Expedited trials in English High Court patent cases
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

UK: Expedited trials in English High Court patent cases

Sponsored by

twobirds-400px.jpg
anne-nygard-sl69jw-o0ru-unsplash.jpg

Jae Park of Bird & Bird takes note of the busy period for the Patents Court in the UK and considers the possibilities of ‘jumping the queue’

Last week of Trinity term, before the courts close for the summer vacation, is usually a very busy period for the High Court. 2021 seems to have been no exception, particularly for the recently appointed Mellor J (sitting as Chancery Interim Applications Judge) who had before him various applications, and among them a number of applications to expedite a patent trial (Abbott Laboratories v Dexcom Incorporated [2021] EWJC 2246 (Pat); Neurim Pharmaceuticals & Flynn Pharma v Generics UK & Mylan [2021] EWHC 2198 (Pat); Philips v Xiaomi [2021] EWHC 2170 (Pat)). 

UK IP practitioners will be aware that the Patents Court has been extremely busy in recent times and there is no sign of things slowing down. However, that has meant that the time to get to trial has been edging upwards – so can an application for expedition help parties to ‘jump the queue’?

Expedition: four Gore factors

Expedition applications are not uncommon, but they are also not the norm. The leading case on expedition generally is Gore v Geox, which sets out four factors to be considered when making the application (the Gore factors):

(1) Whether the applicants have shown good reason for expedition;

(2) Whether expedition would interfere with good administration of justice; 

(3) Whether expedition would cause prejudice to the party; and 

(4) Whether there are any other special factors. 

The Nicoventures points

Expedition applications in patent cases also come before the courts occasionally. The relevant factors applicable to such cases were recently considered in detail by Birss J (as he was then) in Nicoventures v Philip Morris, who added three particular points to the Gore factors: 

(1) The court decides applications for expedition according to the relevant principles, and not simply by approaching them on the basis that someone who happens to come to the court wishing for their case to be speeded up will get it; 

(2) A mere wish for commercial certainty is not enough to justify expedition – a ‘good reason’ has to be established in evidence; and

(3) The court will take the German ‘injunction gap’ into account as a factor, but it is never enough on its own (this is a point that is specific to patent cases, where there are parallel proceedings in Germany).

A feature of the German bifurcated system is that an injunction for infringement may be granted in relation to a patent that is later revoked by the Federal Patent Court, or in EPO opposition proceedings. This is known as the ‘injunction gap’.

The Gore factors (as supplemented in Nicoventures) were considered to differing degrees in the applications before Mellor J in the last week of term. In Abbott v Dexcom, the application for expedition was dismissed, whilst in Neurim v Mylan, the application for expedition was granted as the particular circumstances of the case provided ‘a good reason’ under Gore for a degree of expedition – this was even though one side would be deprived of their chosen lead barrister, which was not regarded as sufficient to outweigh expedition. 

In Philips v Xiaomi, it was not necessary to go into the Gore factors as the issues fell into place by themselves, largely for practical reasons. In particular, when it was put to the parties that the trial, if it were to be expedited, would have to float for an indefinite period – the upshot of the Patents Court being very busy – it quickly became clear that this was an unappealing prospect for both sides. 

Busy period for the Patents Court

All in all, as Birss J pointed out in Nicoventures, the reality is that there are “a large number of litigants in the business and property courts who would like their cases to be tried earlier, therefore granting expedition involves an inevitable degree of queue-jumping and therefore there has to be a good reason for it”. 

That degree of queue-jumping is potentially more substantial in the current times, particularly when the Patents Court (and General Chancery) lists are already very busy, and it is likely to stay that way for a while. It will be interesting to see whether despite that, or rather because of it, we will see more applications for expedition in the future. 

 

Jae Park

Senior associate, Bird & Bird

E: jae.park@twobirds.com

 

more from across site and ros bottom lb

More from across our site

We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Law firms that pay close attention to their client relationships are more likely to win repeat work, according to a survey of nearly 29,000 in-house counsel
The EMEA research period is open until May 31
Practitioners analyse a survey on how law firms prove value to their clients and reflect on why the concept can be hard to pin down
The winner of Managing IP’s Life Achievement Award discusses 50 years in IP law and how even he can’t avoid imposter syndrome
Saya Choudhary of Singh & Singh explains how her team navigated nine years of litigation to secure record damages of $29 million and the lessons learned along the way
The full list of finalists has been revealed and the winners will be presented on June 20 at the Metropolitan Club in New York
A team of IP and media law specialists has joined from SKW Schwarz alongside a former counsel at Sky
The Irish government has delayed a planned referendum on whether Ireland should join the Unified Patent Court, prompting concern about when a vote may take place
With more than 250 winners recognised during the ceremony, there are many reasons to be positive about the health of the IP industry in EMEA
Gift this article